Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression

NACompletedINTERVENTIONAL
Enrollment

948

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

July 31, 2011

Study Completion Date

October 31, 2011

Conditions
HIV InfectionsHelminthiasis
Interventions
DRUG

Albendazole

"Every 3 months for 24 months (enrollment 3, 6, 9, 12, 15, 18, 21, and 24 months):~400mg/day X 3 days"

DRUG

Praziquantel

At enrollment and 12 months: 25mg/kg X 1

DRUG

Current standard of care in Kenya

Current standard of care for HIV patients in Kenya based on WHO guidelines.

Trial Locations (1)

Unknown

Kenya Medical Research Institute, Nairobi

Sponsors
All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Kenya Medical Research Institute

OTHER

lead

University of Washington

OTHER